189.90
price down icon1.35%   -2.60
after-market Dopo l'orario di chiusura: 190.71 0.81 +0.43%
loading
Precedente Chiudi:
$192.50
Aprire:
$192.64
Volume 24 ore:
1.43M
Relative Volume:
0.28
Capitalizzazione di mercato:
$294.50B
Reddito:
$58.80B
Utile/perdita netta:
$10.24B
Rapporto P/E:
57.92
EPS:
3.2788
Flusso di cassa netto:
$8.98B
1 W Prestazione:
-2.22%
1M Prestazione:
-7.61%
6M Prestazione:
+138.69%
1 anno Prestazione:
+148.20%
Intervallo 1D:
Value
$189.43
$193.65
Intervallo di 1 settimana:
Value
$189.35
$198.09
Portata 52W:
Value
$61.24
$212.71

Astrazeneca Plc Stock (AZN) Company Profile

Name
Nome
Astrazeneca Plc
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
96,100
Name
Cinguettio
@AstraZeneca
Name
Prossima data di guadagno
2026-02-10
Name
Ultimi documenti SEC
Name
AZN's Discussions on Twitter

Compare AZN vs LLY, JNJ, ABBV, NVS

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - General icon
AZN
Astrazeneca Plc
189.90 294.50B 58.80B 10.24B 8.98B 3.2788
Drug Manufacturers - General icon
LLY
Lilly Eli Co
985.08 879.67B 65.18B 20.64B 5.96B 22.59
Drug Manufacturers - General icon
JNJ
Johnson Johnson
241.52 582.04B 94.19B 26.80B 19.70B 11.05
Drug Manufacturers - General icon
ABBV
Abbvie Inc
219.68 388.43B 61.16B 4.19B 17.82B 2.3614
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
153.44 292.79B 54.72B 14.02B 15.32B 7.1855

Astrazeneca Plc Stock (AZN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2026-01-27 Iniziato Citigroup Buy
2025-10-27 Ripresa Jefferies Buy
2025-10-16 Downgrade Deutsche Bank Hold → Sell
2025-04-15 Iniziato Exane BNP Paribas Outperform
2025-02-13 Aggiornamento UBS Neutral → Buy
2025-02-12 Iniziato Morgan Stanley Overweight
2024-11-20 Aggiornamento UBS Sell → Neutral
2024-11-06 Aggiornamento Deutsche Bank Sell → Hold
2024-09-13 Downgrade Deutsche Bank Hold → Sell
2024-05-30 Iniziato Goldman Buy
2024-04-16 Aggiornamento Deutsche Bank Sell → Hold
2024-02-08 Downgrade Deutsche Bank Hold → Sell
2024-01-23 Iniziato Morgan Stanley Overweight
2024-01-16 Ripresa UBS Sell
2024-01-03 Downgrade Jefferies Buy → Hold
2023-12-18 Iniziato HSBC Securities Buy
2023-09-25 Aggiornamento Jefferies Hold → Buy
2023-07-14 Iniziato HSBC Securities Buy
2023-07-12 Aggiornamento UBS Neutral → Buy
2023-07-05 Downgrade Deutsche Bank Buy → Hold
2023-04-11 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2023-01-05 Iniziato BMO Capital Markets Outperform
2022-09-15 Downgrade Credit Suisse Outperform → Neutral
2022-09-07 Downgrade Morgan Stanley Overweight → Equal-Weight
2022-08-29 Aggiornamento Argus Hold → Buy
2022-06-14 Downgrade UBS Buy → Neutral
2022-02-11 Aggiornamento DZ Bank Sell → Hold
2021-12-07 Downgrade Jefferies Buy → Hold
2021-08-12 Ripresa JP Morgan Overweight
2021-04-12 Downgrade Argus Buy → Hold
2021-03-16 Aggiornamento Jefferies Hold → Buy
2021-02-25 Aggiornamento UBS Neutral → Buy
2021-01-15 Iniziato Deutsche Bank Buy
2020-12-07 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2020-11-30 Aggiornamento UBS Sell → Neutral
2020-11-11 Aggiornamento HSBC Securities Reduce → Hold
2020-09-29 Iniziato Berenberg Buy
2019-11-22 Iniziato SVB Leerink Outperform
2019-10-25 Aggiornamento Liberum Hold → Buy
2019-04-02 Downgrade UBS Neutral → Sell
2019-02-05 Iniziato Exane BNP Paribas Outperform
2019-01-25 Aggiornamento Shore Capital Hold → Buy
2018-12-11 Ripresa Jefferies Hold
2018-10-09 Iniziato Guggenheim Buy
2018-08-16 Downgrade Jefferies Buy → Hold
2018-03-19 Aggiornamento Jefferies Hold → Buy
2018-02-06 Reiterato Leerink Partners Mkt Perform
2018-02-05 Reiterato Bernstein Outperform
2018-01-18 Reiterato Leerink Partners Mkt Perform
2017-12-29 Aggiornamento JP Morgan Neutral → Overweight
2017-10-16 Aggiornamento Credit Suisse Neutral → Outperform
2017-09-25 Aggiornamento Exane BNP Paribas Neutral → Outperform
2017-09-22 Aggiornamento Bernstein Mkt Perform → Outperform
Mostra tutto

Astrazeneca Plc Borsa (AZN) Ultime notizie

pulisher
08:07 AM

Could This International ETF Be One of the Best Investments of 2026? - The Motley Fool

08:07 AM
pulisher
01:35 AM

Eli Lilly Could Rejoin Abivax Bidding If AstraZeneca Misses Deadline - AOL.com

01:35 AM
pulisher
Mar 13, 2026

Astrazeneca (AZN) Dips More Than Broader Market: What You Should Know - Yahoo Finance Singapore

Mar 13, 2026
pulisher
Mar 13, 2026

Dermatomyositis Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | Octapharma, Argenx, AstraZeneca, Bristol-Myers Squibb Company, Pfizer Inc., Octapharma AG, Corbus Pharma, Holdings - Barchart

Mar 13, 2026
pulisher
Mar 13, 2026

AstraZeneca (LSE:AZN) Valuation Insights After Recent Price Moves - Kalkine Media

Mar 13, 2026
pulisher
Mar 12, 2026

AZN Stock Price and Chart — LSE:AZN - TradingView

Mar 12, 2026
pulisher
Mar 12, 2026

AstraZeneca’s DURGA-4 CAR-T Study Puts New Pressure on Multiple Myeloma Rivals - TipRanks

Mar 12, 2026
pulisher
Mar 12, 2026

AstraZeneca Advances Pediatric Symbicort Device Study, Supporting Long Term Respiratory Strategy - TipRanks

Mar 12, 2026
pulisher
Mar 12, 2026

AstraZeneca (AZN) Refutes Takeover Speculation - GuruFocus

Mar 12, 2026
pulisher
Mar 12, 2026

$100 Million AstraZeneca Deal Puts Chinese Biotech Jacobio on Path to Profit - Caixin Global

Mar 12, 2026
pulisher
Mar 12, 2026

Abivax denies AstraZeneca takeover rumors reported by French media - Reuters

Mar 12, 2026
pulisher
Mar 12, 2026

Abivax Denies La Lettre Report of AstraZeneca Exclusivity - marketscreener.com

Mar 12, 2026
pulisher
Mar 12, 2026

Abivax Denies La Lettre Report of AstraZeneca Exclusivity, Bloomberg Reports - marketscreener.com

Mar 12, 2026
pulisher
Mar 12, 2026

Van ECK Associates Corp Sells 72,809 Shares of AstraZeneca PLC $AZN - MarketBeat

Mar 12, 2026
pulisher
Mar 12, 2026

SageView Advisory Group LLC Acquires New Holdings in AstraZeneca PLC $AZN - MarketBeat

Mar 12, 2026
pulisher
Mar 12, 2026

AstraZeneca (AZN) Enters Exclusive Agreement Boosting Abivax Sha - GuruFocus

Mar 12, 2026
pulisher
Mar 12, 2026

BNP Paribas Financial Markets Increases Stock Position in AstraZeneca PLC $AZN - MarketBeat

Mar 12, 2026
pulisher
Mar 12, 2026

Capital Research Global Investors Raises Stock Holdings in AstraZeneca PLC $AZN - MarketBeat

Mar 12, 2026
pulisher
Mar 12, 2026

AstraZeneca in pole position to acquire Abivax - marketscreener.com

Mar 12, 2026
pulisher
Mar 12, 2026

Morgan Stanley sees double-digit EPS growth for AstraZeneca PLC (AZN) - MSN

Mar 12, 2026
pulisher
Mar 12, 2026

Morgan Stanley Sees Double-Digit EPS Growth for AstraZeneca PLC (AZN) - Insider Monkey

Mar 12, 2026
pulisher
Mar 11, 2026

Franklin Resources Inc. Sells 1,585,664 Shares of AstraZeneca PLC $AZN - MarketBeat

Mar 11, 2026
pulisher
Mar 11, 2026

Russell Investments Group Ltd. Has $66.19 Million Stock Position in AstraZeneca PLC $AZN - MarketBeat

Mar 11, 2026
pulisher
Mar 11, 2026

AstraZeneca PLC $AZN Position Boosted by Bank of Montreal Can - MarketBeat

Mar 11, 2026
pulisher
Mar 11, 2026

In Brief: Jacobio/AZ’s JAB-23E73 Reports First Clinical Results For Pan-KRAS Inhibitors - Citeline News & Insights

Mar 11, 2026
pulisher
Mar 11, 2026

AZN Stock Price, Quote & Chart | ASTRAZENECA PLC-SPONS ADR (NYSE:AZN) - ChartMill

Mar 11, 2026
pulisher
Mar 11, 2026

Zoladex Market Is Booming Worldwide 2026-2033 | AstraZeneca, Pfizer, Ipsen, Novartis - openPR.com

Mar 11, 2026
pulisher
Mar 10, 2026

AstraZeneca awards $3.4 million to US nonprofits to expand healthcare access - MSN

Mar 10, 2026
pulisher
Mar 10, 2026

AstraZeneca schedules digital annual general meeting for April 9 - Investing.com South Africa

Mar 10, 2026
pulisher
Mar 10, 2026

Joshua Jackson, Gritty urge fans to get checked for cancer early - Stock Titan

Mar 10, 2026
pulisher
Mar 10, 2026

AstraZeneca schedules AGM for April 9, 2026 - Investing.com India

Mar 10, 2026
pulisher
Mar 10, 2026

Causeway Capital Management LLC Raises Stock Position in AstraZeneca PLC $AZN - MarketBeat

Mar 10, 2026
pulisher
Mar 10, 2026

Capital International Investors Sells 6,352,463 Shares of AstraZeneca PLC $AZN - MarketBeat

Mar 10, 2026
pulisher
Mar 10, 2026

AstraZeneca PLC $AZN Shares Sold by Capital Group Private Client Services Inc. - MarketBeat

Mar 10, 2026
pulisher
Mar 10, 2026

[6-K] ASTRAZENECA PLC Current Report (Foreign Issuer) | AZN SEC FilingForm 6-K - Stock Titan

Mar 10, 2026
pulisher
Mar 10, 2026

Capital International Inc. CA Buys 18,059 Shares of AstraZeneca PLC $AZN - MarketBeat

Mar 10, 2026
pulisher
Mar 10, 2026

AstraZeneca's Stock Ranks 395th in Trading Activity Amid Institutional Splits and 156% Dividend Yield - Bitget

Mar 10, 2026
pulisher
Mar 10, 2026

First Trust Advisors LP Sells 103,714 Shares of AstraZeneca PLC $AZN - MarketBeat

Mar 10, 2026
pulisher
Mar 10, 2026

Cresset Asset Management LLC Lowers Holdings in AstraZeneca PLC $AZN - MarketBeat

Mar 10, 2026
pulisher
Mar 09, 2026

AstraZeneca and Daiichi Sankyo Enter Global Collaboration to Jointly Develop and Commercialize Enhertu - marketscreener.com

Mar 09, 2026
pulisher
Mar 09, 2026

AstraZeneca PLC $AZN Shares Sold by Victory Capital Management Inc. - MarketBeat

Mar 09, 2026
pulisher
Mar 09, 2026

AstraZeneca (AZN) Achieves Priority Review for Enhertu in Breast Cancer Treatment - GuruFocus

Mar 09, 2026
pulisher
Mar 09, 2026

AstraZeneca, Daiichi Sankyo Wins Priority Review for Enhertu for Breast Cancer - marketscreener.com

Mar 09, 2026
pulisher
Mar 09, 2026

Brokers Offer Predictions for AstraZeneca FY2026 Earnings - MarketBeat

Mar 09, 2026
pulisher
Mar 08, 2026

AstraZeneca (AZN) and Other Drugmakers Watch as Key FDA Official Resigns - GuruFocus

Mar 08, 2026
pulisher
Mar 08, 2026

Natixis Advisors LLC Buys 262,465 Shares of AstraZeneca PLC $AZN - MarketBeat

Mar 08, 2026
pulisher
Mar 08, 2026

Legacy Capital Group California Inc. Buys New Position in AstraZeneca PLC $AZN - MarketBeat

Mar 08, 2026
pulisher
Mar 07, 2026

AstraZeneca PLC $AZN Shares Purchased by Guardian Capital LP - MarketBeat

Mar 07, 2026
pulisher
Mar 06, 2026

AstraZeneca’s AZD5004 Formulation Trial: Early Data Point for Long-Term Pipeline Value - TipRanks

Mar 06, 2026
pulisher
Mar 06, 2026

AstraZeneca executives receive vested shares under deferred bonus plan - Investing.com India

Mar 06, 2026
pulisher
Mar 06, 2026

AstraZeneca CEO Pascal Soriot receives vested shares under performance plan - Investing.com UK

Mar 06, 2026

Astrazeneca Plc Azioni (AZN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
drug_manufacturers_general NVS
$153.44
price down icon 0.53%
drug_manufacturers_general MRK
$115.61
price down icon 0.26%
$219.68
price down icon 2.52%
$366.21
price down icon 0.43%
$144.99
price down icon 0.15%
Capitalizzazione:     |  Volume (24 ore):